HuGE Literature Finder
|
||
Records 1-21
|
Genome-Wide Association Study of Familial Lung Cancer.
Carcinogenesis 2018 Jun . Byun Jinyoung, Schwartz Ann G, Lusk Christine, Wenzlaff Angela S, de Andrade Mariza, Mandal Diptasri, Gaba Colette, Yang Ping, You Ming, Kupert Elena Y, Anderson Marshall W, Han Younghun, Li Yafang, Qian David, Stilp Adrienne, Laurie Cathy, Nelson Sarah, Zheng Wenying, Hung Rayjean J, Gaborieau Valerie, Mckay James, Brennan Paul, Caporaso Neil E, Landi Maria Teresa, Wu Xifeng, McLaughlin John R, Brhane Yonathan, Bossé Yohan, Pinney Susan M, Bailey-Wilson Joan E, Amos Christopher |
|
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
|
Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs.
Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 101-107. Jiang Juhong, Gu Yingying, Liu Jing, Wu Ruibin, Fu Lin, Zhao Jin, Guan Yub |
|
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Molecular cancer 2016 Oct 15 (1): 63. Kovaleva Valentina, Geissler Anna-Lena, Lutz Lisa, Fritsch Ralph, Makowiec Frank, Wiesemann Sebastian, Hopt Ulrich T, Passlick Bernward, Werner Martin, Lassmann Sil |
|
Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) 2016 Sep 99 155-61. Hamasaki Makoto, Matsumoto Shinji, Abe Sousei, Hamatake Daisuke, Kamei Toshiaki, Hiroshima Kenzo, Kawahara Kunimitsu, Sato Ayuko, Tsujimura Tohru, Nakatani Yukio, Yoshida Yasuhiro, Iwasaki Akinori, Nabeshima Kazu |
|
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr . Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San |
|
Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Feb . Koh Young Wha, Chun Sung-Min, Park Young-Soo, Song Joon Seon, Lee Geon Kook, Khang Shin Kwang, Jang Se J |
|
Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Journal of the American Academy of Dermatology 2014 Nov 71 (5): 888-95. Potrony Miriam, Puig-Butillé Joan Anton, Aguilera Paula, Badenas Celia, Carrera Cristina, Malvehy Josep, Puig Susa |
|
Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2014 Jun 68 (5): 521-6. Stankovic Tijana, Milinkovic Vedrana, Bankovic Jasna, Dinic Jelena, Tanic Nasta, Dramicanin Tatjana, Tanic Niko |
|
Comprehensive genomic characterization of squamous cell lung cancers.
Nature 2012 Sep 489 (7417): 519-25. Authors are not available |
|
Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.
Mutagenesis 2012 Jul 27 (4): 423-9. Scesnaite Asta, Jarmalaite Sonata, Mutanen Pertti, Anttila Sisko, Nyberg Fredrik, Benhamou Simone, Boffetta Paolo, Husgafvel-Pursiainen Kirs |
|
LKB1, TP16, EGFR, and KRAS somatic mutations in lung adenocarcinomas from a Chiba Prefecture, Japan cohort.
Drug discoveries & therapeutics 2012 Feb 6 (1): 24-30. Suzuki Y, Oonishi T, Kudo T, Doi |
|
Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
Archives of medical research 2011 Nov 42 (8): 669-76. Tan Cong, Xu He-Yun, Zhang Chen-Ye, Zhang Hu, Chen Chun-Mei, Zhang Wei-Min, Sun Xiao-Yu, Jin Yong-Ta |
|
Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 32-7. Ma Hongxia, Chen Jiaping, Pan Shiyang, Dai Juncheng, Jin Guangfu, Hu Zhibin, Shen Hongbing, Shu Yongqi |
|
Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.
Environmental and molecular mutagenesis 2009 May 50 (4): 285-90. Shen Min, Vermeulen Roel, Rajaraman Preetha, Menashe Idan, He Xingzhou, Chapman Robert S, Yeager Meredith, Thomas Gilles, Burdett Laurie, Hutchinson Amy, Yuenger Jeff, Chanock Stephen, Lan Qi |
|
Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.
Carcinogenesis 2008 Oct 29 (10): 1938-43. Hosgood H Dean, Menashe Idan, Shen Min, Yeager Meredith, Yuenger Jeff, Rajaraman Preetha, He Xingzhou, Chatterjee Nilanjan, Caporaso Neil E, Zhu Yong, Chanock Stephen J, Zheng Tongzhang, Lan Qi |
|
Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe.
Cancer research 2006 Aug 66 (16): 8280-6. Hung Rayjean J, Boffetta Paolo, Canzian Federico, Moullan Norman, Szeszenia-Dabrowska Neonila, Zaridze David, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Foretova Lenka, Janout Vladimir, Bencko Vladimir, Chabrier Amelie, Landi Stefano, Gemignani Federica, Hall Janet, Brennan Pa |
|
CDKN2A common variant and multi-organ cancer risk--a population-based study.
International journal of cancer. Journal international du cancer 2006 Jun 118 (12): 3180-2. Debniak Tadeusz, Scott Rodney J, Huzarski Tomasz, Byrski Tomasz, Rozmiarek Andrzej, Debniak Boguslaw, Górski Bohdan, Cybulski Cezary, Medrek Krzysztof, Mierzejewski Marek, Masojc Bart?omiej, Matyjasik Joanna, Z?owocka Elzbieta, Teodorczyk Urszula, Lener Marcin, Klujszo-Grabowska Ewa, Nej-Wo?osiak Katarzyna, Jaworowska Ewa, Oszutowska Dorota, Szyma?ska Anna, Szyma?ska Jolanta, Castaneda Jennifer, van de Wetering Thierry, Suchy Janina, Kurzawski Grzegorz, Oszurek Oleg, Narod Steven, Lubinski J |
|
Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer.
International journal of cancer. Journal international du cancer 2006 Mar 118 (6): 1364-9. Kraunz Kim S, Nelson Heather H, Lemos Miriam, Godleski John J, Wiencke John K, Kelsey Karl |
|
Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.
Cancer genetics and cytogenetics 2005 Oct 162 (1): 10-20. Chan Eunice C, Lam Shui Y, Fu Kin H, Kwong Yok |
|
Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Cancer research 2002 Apr 62 (8): 2248-52. Gilliland Frank D, Harms Heidi J, Crowell Richard E, Li Yu-Fen, Willink Randy, Belinsky Steven |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 11, 2019
- Content source: